Monthly Archives: October 2021

Patients with inflammatory bowel diseases (IBD), specifically those treated with anti-tumor-necrosis-factor (TNF)α biologics are at high risk for vaccine preventable infections. Their ability to mount adequate vaccine responses is unclear. Continue reading →

Gastroparesis is characterized by symptoms suggestive of and objective evidence of delayed gastric emptying in the absence of mechanical obstruction. This review addresses the normal emptying of solids and liquids from the stomach and details the myoge… Continue reading →

Acinar to ductal metaplasia (ADM) occurs in the pancreas in response to tissue injury and is a potential precursor for adenocarcinoma. The goal of these studies was to define the populations arising from ADM, the associated transcriptional changes, and… Continue reading →

Gastroenterology is the premiere journal in the field of gastrointestinal disease and is led by an internationally renowned board of editors. As the official journal of the AGA Institute, Gastroenterology delivers up-to-date and authoritative coverage … Continue reading →

Gut virome composition varies by irritable bowel syndrome phenotype and demonstrates stability in individuals through time, with the ability to mediate gut bacteria and host gene expression. Continue reading →